Brief: SMS Lifesciences India Acquires 1 Mln Shares In Mahi Drugs
17/09/2018 11:48
Sept 17 (Reuters) - SMS Lifesciences India Ltd SMSL.NS :
* FURTHER ACQUIRED 1 MILLION SHARES IN MAHI DRUGS, MAKING IT
CO'S
UNIT
Source text: http://bit.ly/2MHQgad
Further company coverage: SMSL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls